Aaropime

Aaropime Injection - 2.25 gm by Aarokiyam Lifesciences containing Cefepime and Tazobactam for Injection.

Aaropime Injection is a powerful antibiotic formulation that contains Cefepime and Tazobactam. It effectively treats a range of serious bacterial infections. This combination enhances efficacy by targeting bacteria that produce beta-lactamase enzymes, which frequently resist standard antibiotics. Cefepime, a fourth-generation cephalosporin, disrupts bacterial cell wall synthesis.

Tazobactam, on the other hand, inhibits the enzymes that break down antibiotics. This powerful combination is marketed and supplied by the reputable Aarokiyam Lifesciences. This company is a trusted name in the pharmaceutical industry, known for its commitment to quality, safety, and reliability. It is typically administered via intravenous (IV) or intramuscular (IM) routes under medical supervision.

What is Cefepime and Tazobactam for Injection?

This medication contains two active ingredients:  

Cefepime: A fourth-generation cephalosporin antibiotic that inhibits the formation of bacterial cell walls, leading to cell death.  

Tazobactam: A beta-lactamase inhibitor that prevents bacterial enzymes from degrading cefepime, enhancing its efficacy.  

Together, they offer a broad-spectrum antibacterial effect, making them effective against various resistant bacterial types.

Mechanism of Action

Cefepime: Cefepime inhibits the formation of bacterial cell walls by binding to penicillin-binding proteins, resulting in cell lysis.

Tazobactam: Tazobactam inhibits beta-lactamase enzymes produced by certain bacteria, preventing the breakdown of cefepime.

This synergistic activity enhances the treatment’s effectiveness against beta-lactamase-producing bacteria.

Indications and Uses

Cefepime with Tazobactam for Injection treats for :

  • Pneumonia:

    This includes both hospital-acquired and ventilator-associated pneumonia.

     

  • Urinary Tract Infections (UTIs):

    UTIs are classified as either complicated or uncomplicated.

     

  • Infections of the skin and soft tissues include cellulitis and wound infections.

     

  • Intra-abdominal infections include peritonitis.

     

  • Doctors use empiric treatment for individuals with febrile neutropenia.

This combination is particularly useful for treating infections caused by bacteria resistant to other antibiotics.

Dosages and Administration of Aaropime Injection

    • Dosage:

      The average adult dose is 2.25 grammes given intravenously every 8 to 12 hours, depending on the severity of the infection and kidney function.

     

    • Administration:

      Intravenous infusion for 30 minutes.

     

    • Duration:

      Treatment duration varies depending on the type of illness and the patient’s reaction, but it normally ranges between 7 and 14 days.

     

    • Note: Patients with renal impairment may require dosage changes.

Possible side effects to be aware of

Every medication may cause negative effects: 

  • little soreness or oedema at the injection site.
  • skin rash or redness
  • Some people may experience nausea or headaches.
  • Rare allergic reactions—inform your doctor right away.
  • If you experience any unexpected symptoms, consult your doctor.

Serious adverse effects are rare but may include allergic reactions and neurotoxicity, especially in patients with renal failure.

Precautions

      • Allergies: Exercise caution in patients with a history of beta-lactam allergy.

       

      • Renal Impairment: Adjust dosages and monitor renal function.

       

      • Pregnancy and lactation: Use only when absolutely necessary; consult a healthcare provider.

       

      • Superinfection: Prolonged use may result in the growth of non-susceptible organisms.

Storage and Handling Guidelines

  • Proper handling provides maximum potency and safety.
  • Keep below 25°C in a dry location.
  • Stay away from sunshine and moisture.
  • Use the reconstituted solution immediately.
  • Do not use if the vial is fractured or discoloured.
  • Keep out of reach of kids.

Why Choose Aaropime Injection - 2.25 mg from Aarokiyam Lifesciences?

  • Quality Assurance:

    Produced under strict quality control standards.

  • Trusted Supplier:

    Aarokiyam Lifesciences is known for reliable pharmaceutical products.

  • Comprehensive Support:

    Provides thorough product information and assistance to healthcare professionals.

  • Wide Distribution:

    Ensures timely availability throughout multiple geographies.

FAQs

 

It effectively treats serious bacterial infections such as pneumonia, urinary tract infections, skin infections, intra-abdominal infections, and febrile neutropenia.

A healthcare professional administers it intravenously every 8 to 12 hours.

Yes, however, dosage adjustments are necessary, and renal function should be monitored.

Serious adverse effects are rare but may include allergic reactions and neurotoxicity, particularly in patients with renal impairment.

Aarokiyam Lifesciences is a reputable supplier. This company stands out for its high-quality products and reliable distribution.

AAROPIME Injection

Brand Name: Aaropime Injection – 2.25 gm

Active Ingredients: Cefepime 2 gm + Tazobactam 0.25 gm

Marketer & Supplier: Aarokiyam Lifesciences

Route of Use: IM/IV

 Availability: On hospital supply orders & medical distributors

 Category: Antibiotic – Cephalosporin + Beta-lactamase Inhibitor

Contact Us

Want to discuss bulk orders?

Please complete the online form if you have any questions or would like to talk about large orders. When you require any information, our employees will get back to you right away. To satisfy your healthcare demands, we at Aarokiyam Lifescience are dedicated to offering top-notch products and outstanding service.

Discover the Aarokiyam difference, where compassionate care and cutting-edge inhalation therapies combine to bring better health to life.